IRADIMED CORP — Director's Dealing 2022

Jul 8, 2022

SEC Form 4/A — Form 4/A

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2022-06-20

Reporting Person: GLENN JOHN (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-20	Restricted Stock Units	$	A	23183	Acquired		Common Stock (23183)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock.

F2: The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on June 20, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

F3: This Form 4/A is being filed solely to correct administrative errors in (i) the number of shares of Common Stock underlying Restricted Stock Units shown as acquired and beneficially held by the reporting person and (ii) the vesting commencement date of such Restricted Stock Units in his Form 4 filed on June 23, 2022 (the "Original Form 4"). All other information set forth in the Original Form 4 remains correct.